Dr. Reddy's Laboratories Limited RDY reported second-quarter fiscal 2026 earnings of 19 cents per American Depositary Share (ADS), which beat the Zacks Consensus Estimate of 18 cents. The company ...

Dr Reddy's Q2 Results FY2026: Dr Reddy's Laboratories reported its Q2FY26 results, posting a revenue of Rs 8,805 crore, up 9.8 per cent from Rs 8,016 crore in Q2FY25. The company's EBITDA stood at Rs ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy’s Laboratories Ltd. (RDY) on Friday reported earnings of $162 million in its fiscal second quarter. On a per-share basis, the Hyderabad, India ...

AVT03 is a proposed biosimilar candidate to Prolia and Xgeva, developed by Alvotech hf. The application was submitted by Dr ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (ROY) reported, under IFRS standards, that its second quarter profit attributable to equity holders of the parent company increased to INR 14.37 billion or ...

Dr Reddy's Laboratories announced that its wholly owned subsidiary, Dr. Reddy's Laboratories SA, Switzerland, has received a Complete Response Letter (CRL) from the USFDA for its Biologics License ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy's Laboratories Ltd. (RDY) on Friday reported earnings of $162 million in its fiscal second quarter. On a per-share basis, the Hyderabad, India ...